speb/financial-data huggingface dataset:
IMUX income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -120407000.00
IMUX income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -120407000.00
IMUX income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -120407000.00
IMUX income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -120407000.00
IMUX cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -120407000.00
IMUX income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -120407000.00
IMUX income_statement (annual, 2022-12-31) — Net Interest Income: 1041000.00
IMUX cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -9629000.00
IMUX income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 1041000.00
IMUX balance_sheet (annual, 2022-12-31) — Net PPE: 1846000.00
IMUX cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -112000.00
IMUX cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 55989000.00
IMUX balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 113684000.00
IMUX income_statement (annual, 2022-12-31) — Normalized EBITDA: -53471000.00
IMUX income_statement (annual, 2022-12-31) — Normalized Income: -87437000.00
IMUX cash_flow (annual, 2022-12-31) — Operating Cash Flow: -65144000.00
IMUX cash_flow (annual, 2022-12-31) — Operating Gains Losses: 4757000.00
IMUX income_statement (annual, 2022-12-31) — Operating Income: -86518000.00
IMUX income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
IMUX balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 3930728.00
IMUX balance_sheet (annual, 2022-12-31) — Other Current Assets: 1225000.00
IMUX balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 239000.00
IMUX balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 3035000.00
IMUX income_statement (annual, 2022-12-31) — Other Gand A: 15263000.00
IMUX income_statement (annual, 2022-12-31) — Other Income Expense: -34930000.00
IMUX balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 43000.00
IMUX income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -1960000.00
IMUX balance_sheet (annual, 2022-12-31) — Other Payable: 532000.00
IMUX balance_sheet (annual, 2022-12-31) — Other Properties: 1846000.00
IMUX balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 9629000.00
IMUX balance_sheet (annual, 2022-12-31) — Payables: 4281000.00
IMUX balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 11377000.00
IMUX balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 890000.00
IMUX balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
IMUX cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 55989000.00
IMUX balance_sheet (annual, 2022-12-31) — Prepaid Assets: 5608000.00
IMUX income_statement (annual, 2022-12-31) — Pretax Income: -120407000.00
IMUX cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 187000.00
IMUX cash_flow (annual, 2022-12-31) — Purchase Of Investment: -9629000.00
IMUX cash_flow (annual, 2022-12-31) — Purchase Of PPE: -112000.00
IMUX balance_sheet (annual, 2022-12-31) — Receivables: 2657000.00
IMUX income_statement (annual, 2022-12-31) — Reconciled Depreciation: 77000.00
IMUX income_statement (annual, 2022-12-31) — Research And Development: 71255000.00
IMUX balance_sheet (annual, 2022-12-31) — Retained Earnings: -317280000.00
IMUX income_statement (annual, 2022-12-31) — Selling General And Administration: 15263000.00
IMUX balance_sheet (annual, 2022-12-31) — Share Issued: 3930728.00
IMUX income_statement (annual, 2022-12-31) — Special Income Charges: -32970000.00
IMUX cash_flow (annual, 2022-12-31) — Stock Based Compensation: 7929000.00
IMUX balance_sheet (annual, 2022-12-31) — Stockholders Equity: 113684000.00
IMUX balance_sheet (annual, 2022-12-31) — Tangible Book Value: 113684000.00
IMUX income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
IMUX income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
IMUX balance_sheet (annual, 2022-12-31) — Taxes Receivable: 2657000.00
IMUX balance_sheet (annual, 2022-12-31) — Total Assets: 127753000.00
IMUX balance_sheet (annual, 2022-12-31) — Total Capitalization: 113684000.00
IMUX balance_sheet (annual, 2022-12-31) — Total Debt: 1563000.00
IMUX balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 113684000.00
IMUX income_statement (annual, 2022-12-31) — Total Expenses: 86518000.00
IMUX balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 14069000.00
IMUX balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1889000.00
IMUX balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 992000.00
IMUX income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -119488000.00
IMUX income_statement (annual, 2022-12-31) — Total Unusual Items: -32970000.00
IMUX income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -32970000.00
IMUX balance_sheet (annual, 2022-12-31) — Working Capital: 112787000.00
IMUX income_statement (annual, 2023-12-31) — +Operating Expense: 99223000.00
IMUX income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
IMUX balance_sheet (annual, 2023-12-31) — Accounts Payable: 4726000.00
IMUX balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 436060000.00
IMUX cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
IMUX income_statement (annual, 2023-12-31) — Basic Average Shares: 4432005.00
IMUX income_statement (annual, 2023-12-31) — Basic EPS: -21.10
IMUX cash_flow (annual, 2023-12-31) — Beginning Cash Position: 106745000.00
IMUX cash_flow (annual, 2023-12-31) — Capital Expenditure: -334000.00
IMUX balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 1334000.00
IMUX balance_sheet (annual, 2023-12-31) — Capital Stock: 4000.00
IMUX balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 46674000.00
IMUX balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 46674000.00
IMUX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 1033000.00
IMUX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 9462000.00
IMUX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -70828000.00
IMUX cash_flow (annual, 2023-12-31) — Change In Account Payable: 817000.00
IMUX cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 10277000.00
IMUX cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 3858000.00
IMUX cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 96000.00
IMUX cash_flow (annual, 2023-12-31) — Change In Payable: 817000.00
IMUX cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 11094000.00
IMUX cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 3858000.00
IMUX cash_flow (annual, 2023-12-31) — Change In Working Capital: 15048000.00
IMUX cash_flow (annual, 2023-12-31) — Changes In Cash: -60333000.00
IMUX balance_sheet (annual, 2023-12-31) — Common Stock: 4000.00
IMUX balance_sheet (annual, 2023-12-31) — Common Stock Equity: 28931000.00
IMUX cash_flow (annual, 2023-12-31) — Common Stock Issuance: 853000.00
IMUX balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 17204000.00
IMUX balance_sheet (annual, 2023-12-31) — Current Assets: 52534000.00
IMUX balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 695000.00
IMUX balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 695000.00
IMUX balance_sheet (annual, 2023-12-31) — Current Liabilities: 24729000.00
IMUX cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 111000.00
IMUX cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 111000.00
IMUX income_statement (annual, 2023-12-31) — Diluted Average Shares: 4432005.00
IMUX income_statement (annual, 2023-12-31) — Diluted EPS: -21.10
IMUX income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -93612000.00
IMUX income_statement (annual, 2023-12-31) — EBIT: -99223000.00
IMUX income_statement (annual, 2023-12-31) — EBITDA: -99112000.00
IMUX cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 262000.00
IMUX cash_flow (annual, 2023-12-31) — End Cash Position: 46674000.00
IMUX cash_flow (annual, 2023-12-31) — Financing Cash Flow: 1033000.00
IMUX cash_flow (annual, 2023-12-31) — Free Cash Flow: -71162000.00
IMUX balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 3759000.00
IMUX income_statement (annual, 2023-12-31) — General And Administrative Expense: 16008000.00
IMUX balance_sheet (annual, 2023-12-31) — Gross PPE: 1765000.00
IMUX income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
IMUX income_statement (annual, 2023-12-31) — Interest Income: 3075000.00
IMUX income_statement (annual, 2023-12-31) — Interest Income Non Operating: 3075000.00
IMUX balance_sheet (annual, 2023-12-31) — Invested Capital: 28931000.00
IMUX cash_flow (annual, 2023-12-31) — Investing Cash Flow: 9462000.00
IMUX cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 853000.00
IMUX balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 639000.00
IMUX balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 639000.00
IMUX cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 853000.00
IMUX cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 523000.00
IMUX income_statement (annual, 2023-12-31) — Net Income: -93612000.00
IMUX income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -93612000.00
IMUX income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -93612000.00
IMUX income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -93612000.00
IMUX income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -93612000.00
IMUX cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -93612000.00
IMUX income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -93612000.00
IMUX income_statement (annual, 2023-12-31) — Net Interest Income: 3075000.00
IMUX cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 9796000.00
IMUX income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 3075000.00
IMUX balance_sheet (annual, 2023-12-31) — Net PPE: 1765000.00
IMUX cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -334000.00
IMUX cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 0.00
IMUX balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 28931000.00
IMUX income_statement (annual, 2023-12-31) — Normalized EBITDA: -99112000.00
IMUX income_statement (annual, 2023-12-31) — Normalized Income: -93612000.00
IMUX cash_flow (annual, 2023-12-31) — Operating Cash Flow: -70828000.00
IMUX cash_flow (annual, 2023-12-31) — Operating Gains Losses: 523000.00
IMUX income_statement (annual, 2023-12-31) — Operating Income: -99223000.00
IMUX income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
IMUX balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 4517773.00
IMUX balance_sheet (annual, 2023-12-31) — Other Current Assets: 1069000.00
IMUX balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 271000.00
IMUX balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 3759000.00
IMUX income_statement (annual, 2023-12-31) — Other Gand A: 16008000.00
IMUX income_statement (annual, 2023-12-31) — Other Income Expense: 2536000.00
IMUX income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 2536000.00
IMUX balance_sheet (annual, 2023-12-31) — Other Payable: 373000.00
IMUX balance_sheet (annual, 2023-12-31) — Other Properties: 1765000.00
IMUX balance_sheet (annual, 2023-12-31) — Other Receivables: 1104000.00
IMUX balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 0.00
IMUX balance_sheet (annual, 2023-12-31) — Payables: 5099000.00
IMUX balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 22303000.00
IMUX balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1460000.00
IMUX balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
IMUX cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 0.00
IMUX balance_sheet (annual, 2023-12-31) — Prepaid Assets: 2314000.00
IMUX income_statement (annual, 2023-12-31) — Pretax Income: -93612000.00
IMUX cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 180000.00
IMUX cash_flow (annual, 2023-12-31) — Purchase Of PPE: -334000.00
IMUX balance_sheet (annual, 2023-12-31) — Receivables: 2477000.00
IMUX income_statement (annual, 2023-12-31) — Reconciled Depreciation: 111000.00
IMUX income_statement (annual, 2023-12-31) — Research And Development: 83215000.00
IMUX balance_sheet (annual, 2023-12-31) — Retained Earnings: -410892000.00
IMUX cash_flow (annual, 2023-12-31) — Sale Of Investment: 9796000.00
IMUX income_statement (annual, 2023-12-31) — Selling General And Administration: 16008000.00
IMUX balance_sheet (annual, 2023-12-31) — Share Issued: 4517773.00
IMUX income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
IMUX cash_flow (annual, 2023-12-31) — Stock Based Compensation: 7102000.00
IMUX balance_sheet (annual, 2023-12-31) — Stockholders Equity: 28931000.00
IMUX balance_sheet (annual, 2023-12-31) — Tangible Book Value: 28931000.00
IMUX income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
IMUX income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
IMUX balance_sheet (annual, 2023-12-31) — Taxes Receivable: 1373000.00
IMUX balance_sheet (annual, 2023-12-31) — Total Assets: 54299000.00
IMUX balance_sheet (annual, 2023-12-31) — Total Capitalization: 28931000.00
IMUX balance_sheet (annual, 2023-12-31) — Total Debt: 1334000.00
IMUX balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 28931000.00
IMUX income_statement (annual, 2023-12-31) — Total Expenses: 99223000.00
IMUX balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 25368000.00
IMUX balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 1765000.00
IMUX balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 639000.00
IMUX income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -99223000.00
IMUX income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
IMUX income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
IMUX balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
IMUX balance_sheet (annual, 2023-12-31) — Working Capital: 27805000.00
IMUX income_statement (quarterly, 2024-09-30) — Basic Average Shares: 10127258.00
IMUX income_statement (quarterly, 2024-09-30) — Basic EPS: -2.40
IMUX cash_flow (quarterly, 2024-09-30) — Depreciation: 42000.00
IMUX income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 10127258.00
IMUX income_statement (quarterly, 2024-09-30) — Diluted EPS: -2.40
IMUX cash_flow (quarterly, 2024-09-30) — Net Investment Purchase And Sale: 0.00
IMUX cash_flow (quarterly, 2024-09-30) — Operating Gains Losses: 56000.00
IMUX cash_flow (quarterly, 2024-09-30) — Proceeds From Stock Option Exercised: 74273000.00
IMUX cash_flow (quarterly, 2024-09-30) — Sale Of Investment: 0.00
IMUX income_statement (annual, 2024-12-31) — +Operating Expense: 98052000.00
IMUX income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
IMUX balance_sheet (annual, 2024-12-31) — Accounts Payable: 7561000.00
IMUX balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 525611000.00
IMUX income_statement (annual, 2024-12-31) — Basic Average Shares: 10017476.00
IMUX income_statement (annual, 2024-12-31) — Basic EPS: -10.00
IMUX cash_flow (annual, 2024-12-31) — Beginning Cash Position: 46674000.00
IMUX cash_flow (annual, 2024-12-31) — Capital Expenditure: -264000.00
IMUX balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 1004000.00
IMUX balance_sheet (annual, 2024-12-31) — Capital Stock: 8000.00
IMUX balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 35668000.00
IMUX balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 35668000.00
IMUX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 74541000.00
IMUX cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: 77000.00
IMUX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -264000.00
IMUX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -84766000.00
IMUX cash_flow (annual, 2024-12-31) — Change In Account Payable: 3145000.00
IMUX cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -4860000.00
IMUX cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 1886000.00
IMUX cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 159000.00
IMUX cash_flow (annual, 2024-12-31) — Change In Payable: 3145000.00
IMUX cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -1715000.00
IMUX cash_flow (annual, 2024-12-31) — Change In Working Capital: 330000.00
IMUX cash_flow (annual, 2024-12-31) — Changes In Cash: -10489000.00
IMUX balance_sheet (annual, 2024-12-31) — Common Stock: 8000.00
IMUX balance_sheet (annual, 2024-12-31) — Common Stock Equity: 18429000.00
IMUX cash_flow (annual, 2024-12-31) — Common Stock Issuance: 191000.00
IMUX cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
IMUX balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 12559000.00
IMUX balance_sheet (annual, 2024-12-31) — Current Assets: 39332000.00
IMUX balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 740000.00
IMUX balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 740000.00
IMUX balance_sheet (annual, 2024-12-31) — Current Liabilities: 22175000.00
IMUX cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 134000.00
IMUX cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 134000.00
IMUX income_statement (annual, 2024-12-31) — Diluted Average Shares: 10017476.00
IMUX income_statement (annual, 2024-12-31) — Diluted EPS: -10.00
IMUX income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -100507000.00
IMUX income_statement (annual, 2024-12-31) — EBIT: -98052000.00
IMUX income_statement (annual, 2024-12-31) — EBITDA: -97918000.00
IMUX cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -517000.00
IMUX cash_flow (annual, 2024-12-31) — End Cash Position: 35668000.00
IMUX cash_flow (annual, 2024-12-31) — Financing Cash Flow: 74541000.00
IMUX cash_flow (annual, 2024-12-31) — Free Cash Flow: -85030000.00
IMUX income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -4796000.00
IMUX income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 0.00
IMUX balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 4209000.00
IMUX income_statement (annual, 2024-12-31) — General And Administrative Expense: 18006000.00
IMUX balance_sheet (annual, 2024-12-31) — Gross PPE: 1536000.00
IMUX income_statement (annual, 2024-12-31) — Interest Income: 3390000.00
IMUX income_statement (annual, 2024-12-31) — Interest Income Non Operating: 3390000.00
IMUX balance_sheet (annual, 2024-12-31) — Invested Capital: 18429000.00
IMUX cash_flow (annual, 2024-12-31) — Investing Cash Flow: -264000.00
IMUX cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 191000.00
IMUX cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
IMUX balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 264000.00
IMUX balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 264000.00
IMUX cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 191000.00
IMUX cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
IMUX cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 30000.00
IMUX cash_flow (quarterly, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 121000.00
IMUX income_statement (annual, 2024-12-31) — Net Income: -100507000.00
IMUX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -100507000.00
IMUX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -100507000.00
IMUX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -100507000.00
IMUX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -100507000.00
IMUX cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -100507000.00
IMUX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -100507000.00
IMUX income_statement (annual, 2024-12-31) — Net Interest Income: 3390000.00
IMUX cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 0.00
IMUX cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 0.00
IMUX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 3390000.00
IMUX cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 74273000.00
IMUX balance_sheet (annual, 2024-12-31) — Net PPE: 1536000.00
IMUX cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -264000.00
IMUX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 18429000.00
IMUX income_statement (annual, 2024-12-31) — Normalized EBITDA: -97918000.00
IMUX income_statement (annual, 2024-12-31) — Normalized Income: -100507000.00
IMUX cash_flow (annual, 2024-12-31) — Operating Cash Flow: -84766000.00
IMUX cash_flow (annual, 2024-12-31) — Operating Gains Losses: 30000.00
IMUX cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: -4675000.00
IMUX income_statement (annual, 2024-12-31) — Operating Income: -98052000.00
IMUX income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
IMUX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 9015086.00
IMUX balance_sheet (annual, 2024-12-31) — Other Current Assets: 1109000.00
IMUX balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 676000.00
IMUX balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 4209000.00
IMUX income_statement (annual, 2024-12-31) — Other Gand A: 18006000.00
IMUX income_statement (annual, 2024-12-31) — Other Income Expense: -5845000.00
IMUX cash_flow (annual, 2024-12-31) — Other Non Cash Items: 6720000.00
IMUX income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -5845000.00
IMUX balance_sheet (annual, 2024-12-31) — Other Payable: 285000.00
IMUX balance_sheet (annual, 2024-12-31) — Other Properties: 1536000.00
IMUX balance_sheet (annual, 2024-12-31) — Payables: 7846000.00
IMUX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 20405000.00
IMUX balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 354000.00
IMUX balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
IMUX balance_sheet (annual, 2024-12-31) — Prepaid Assets: 1871000.00
IMUX income_statement (annual, 2024-12-31) — Pretax Income: -100507000.00
IMUX cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 77000.00
IMUX cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: -74196000.00
IMUX cash_flow (annual, 2024-12-31) — Purchase Of PPE: -264000.00
IMUX balance_sheet (annual, 2024-12-31) — Receivables: 684000.00
IMUX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 134000.00
IMUX income_statement (annual, 2024-12-31) — Research And Development: 80046000.00
IMUX balance_sheet (annual, 2024-12-31) — Retained Earnings: -511399000.00
IMUX cash_flow (annual, 2024-12-31) — Sale Of Investment: 0.00
IMUX cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 0.00
IMUX income_statement (annual, 2024-12-31) — Selling General And Administration: 18006000.00
IMUX balance_sheet (annual, 2024-12-31) — Share Issued: 9015086.00
IMUX cash_flow (annual, 2024-12-31) — Stock Based Compensation: 8527000.00
IMUX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 18429000.00
IMUX balance_sheet (annual, 2024-12-31) — Tangible Book Value: 18429000.00
IMUX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
IMUX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
IMUX balance_sheet (annual, 2024-12-31) — Taxes Receivable: 684000.00
IMUX balance_sheet (annual, 2024-12-31) — Total Assets: 40868000.00
IMUX balance_sheet (annual, 2024-12-31) — Total Capitalization: 18429000.00
IMUX balance_sheet (annual, 2024-12-31) — Total Debt: 1004000.00
IMUX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 18429000.00
IMUX income_statement (annual, 2024-12-31) — Total Expenses: 98052000.00
IMUX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 22439000.00
IMUX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 1536000.00
IMUX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 264000.00
IMUX income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -98052000.00
IMUX income_statement (annual, 2024-12-31) — Total Unusual Items: -4796000.00
IMUX income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
IMUX income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -4796000.00
IMUX income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
IMUX balance_sheet (annual, 2024-12-31) — Working Capital: 17157000.00
IMUX income_statement (quarterly, 2025-03-31) — +Operating Expense: 26825000.00
IMUX income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
IMUX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 5507000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 527653000.00
IMUX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 10134443.00
IMUX income_statement (quarterly, 2025-03-31) — Basic EPS: -2.51
IMUX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 35668000.00
IMUX cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -47000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 975000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 8000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 14304000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 14304000.00
IMUX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 0.00
IMUX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -47000.00
IMUX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -21776000.00
IMUX cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -2083000.00
IMUX cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 4711000.00
IMUX cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -839000.00
IMUX cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -230000.00
IMUX cash_flow (quarterly, 2025-03-31) — Change In Payable: -2083000.00
IMUX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 2628000.00
IMUX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 1559000.00
IMUX cash_flow (quarterly, 2025-03-31) — Changes In Cash: -21823000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Common Stock: 8000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -5287000.00
IMUX cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
IMUX balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 17510000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Current Assets: 18975000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 765000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 765000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 25592000.00
IMUX cash_flow (quarterly, 2025-03-31) — Depreciation: 43000.00
IMUX cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 43000.00
IMUX cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 43000.00
IMUX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 10134443.00
IMUX income_statement (quarterly, 2025-03-31) — Diluted EPS: -2.51
IMUX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -25473000.00
IMUX income_statement (quarterly, 2025-03-31) — EBIT: -26825000.00
IMUX income_statement (quarterly, 2025-03-31) — EBITDA: -26782000.00
IMUX cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 459000.00
IMUX cash_flow (quarterly, 2025-03-31) — End Cash Position: 14304000.00
IMUX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 0.00
IMUX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -21823000.00
IMUX cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
IMUX balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 3924000.00
IMUX income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 5292000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Gross PPE: 1540000.00
IMUX income_statement (quarterly, 2025-03-31) — Interest Income: 183000.00
IMUX income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 183000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Invested Capital: -5287000.00
IMUX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -47000.00
IMUX cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
IMUX balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 210000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 210000.00
IMUX cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
IMUX cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 0.00
IMUX income_statement (quarterly, 2025-03-31) — Net Income: -25473000.00
IMUX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -25473000.00
IMUX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -25473000.00
IMUX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -25473000.00
IMUX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -25473000.00
IMUX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -25473000.00
IMUX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -25473000.00
IMUX income_statement (quarterly, 2025-03-31) — Net Interest Income: 183000.00
IMUX income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 183000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Net PPE: 1540000.00
IMUX cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -47000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -5287000.00
IMUX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -26782000.00
IMUX income_statement (quarterly, 2025-03-31) — Normalized Income: -25473000.00
IMUX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -21776000.00
IMUX income_statement (quarterly, 2025-03-31) — Operating Income: -26825000.00
IMUX income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
IMUX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 9015086.00
IMUX balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 1254000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 527000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 3924000.00
IMUX income_statement (quarterly, 2025-03-31) — Other Gand A: 5292000.00
IMUX income_statement (quarterly, 2025-03-31) — Other Income Expense: 1169000.00
IMUX cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 53000.00
IMUX income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 1169000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Other Payable: 504000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Other Properties: 1540000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1082000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Payables: 6011000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 23521000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 779000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
IMUX balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 1704000.00
IMUX income_statement (quarterly, 2025-03-31) — Pretax Income: -25473000.00
IMUX cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -47000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Receivables: 1713000.00
IMUX income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 43000.00
IMUX income_statement (quarterly, 2025-03-31) — Research And Development: 21533000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -536872000.00
IMUX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 5292000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Share Issued: 9015086.00
IMUX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 2042000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: -5287000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -5287000.00
IMUX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
IMUX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
IMUX balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 631000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Total Assets: 20515000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: -5287000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Total Debt: 975000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -5287000.00
IMUX income_statement (quarterly, 2025-03-31) — Total Expenses: 26825000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 25802000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1540000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 210000.00
IMUX income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -26825000.00
IMUX balance_sheet (quarterly, 2025-03-31) — Working Capital: -6617000.00
IMUX income_statement (quarterly, 2025-06-30) — +Operating Expense: 27083000.00
IMUX income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
IMUX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 7015000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 595069000.00
IMUX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 13217520.00
IMUX income_statement (quarterly, 2025-06-30) — Basic EPS: -2.00
IMUX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 14304000.00
IMUX cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -36000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 979000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 9000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 55310000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 55310000.00
IMUX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 65518000.00
IMUX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -36000.00
IMUX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -24609000.00
IMUX cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 1187000.00
IMUX cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -1264000.00
IMUX cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 410000.00
IMUX cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -119000.00
IMUX cash_flow (quarterly, 2025-06-30) — Change In Payable: 1187000.00
IMUX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -77000.00
IMUX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 214000.00
IMUX cash_flow (quarterly, 2025-06-30) — Changes In Cash: 40873000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Common Stock: 9000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 33911000.00
IMUX cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 65395000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 16656000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Current Assets: 59842000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 774000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 774000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 27313000.00
IMUX cash_flow (quarterly, 2025-06-30) — Depreciation: 43000.00
IMUX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 43000.00
IMUX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 43000.00
IMUX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 13217520.00
IMUX income_statement (quarterly, 2025-06-30) — Diluted EPS: -2.00
IMUX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -26820000.00
IMUX income_statement (quarterly, 2025-06-30) — EBIT: -27083000.00
IMUX income_statement (quarterly, 2025-06-30) — EBITDA: -27040000.00
IMUX cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 133000.00
IMUX cash_flow (quarterly, 2025-06-30) — End Cash Position: 55310000.00
IMUX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 65518000.00
IMUX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -24645000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 2525000.00
IMUX income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 5714000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 1587000.00
IMUX income_statement (quarterly, 2025-06-30) — Interest Income: 241000.00
IMUX income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 241000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 33911000.00
IMUX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -36000.00
IMUX cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 65395000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 205000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 205000.00
IMUX cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 65395000.00
IMUX cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 0.00
IMUX income_statement (quarterly, 2025-06-30) — Net Income: -26820000.00
IMUX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -26820000.00
IMUX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -26820000.00
IMUX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -26820000.00
IMUX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -26820000.00
IMUX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -26820000.00
IMUX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -26820000.00
IMUX income_statement (quarterly, 2025-06-30) — Net Interest Income: 241000.00
IMUX income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 241000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Net PPE: 1587000.00
IMUX cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -36000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 33911000.00
IMUX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -27040000.00
IMUX income_statement (quarterly, 2025-06-30) — Normalized Income: -26820000.00
IMUX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -24609000.00
IMUX income_statement (quarterly, 2025-06-30) — Operating Income: -27083000.00
IMUX income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
IMUX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 9865059.00
IMUX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 861000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 533000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 2525000.00
IMUX income_statement (quarterly, 2025-06-30) — Other Gand A: 5714000.00
IMUX income_statement (quarterly, 2025-06-30) — Other Income Expense: 22000.00
IMUX cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 55000.00
IMUX income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 22000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Other Payable: 878000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Other Properties: 1587000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Payables: 7893000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 24549000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 1457000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
IMUX balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 3077000.00
IMUX income_statement (quarterly, 2025-06-30) — Pretax Income: -26820000.00
IMUX cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -36000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Receivables: 594000.00
IMUX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 43000.00
IMUX income_statement (quarterly, 2025-06-30) — Research And Development: 21369000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -563692000.00
IMUX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 5714000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Share Issued: 9865059.00
IMUX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 1899000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 33911000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 33911000.00
IMUX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
IMUX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
IMUX balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 594000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Total Assets: 61429000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 33911000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Total Debt: 979000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 33911000.00
IMUX income_statement (quarterly, 2025-06-30) — Total Expenses: 27083000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 27518000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1587000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 205000.00
IMUX income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -27083000.00
IMUX balance_sheet (quarterly, 2025-06-30) — Working Capital: 32529000.00
IMUX income_statement (quarterly, 2025-09-30) — +Operating Expense: 25993000.00
IMUX income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
IMUX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 7349000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 597179000.00
IMUX income_statement (quarterly, 2025-09-30) — Basic Average Shares: 19389776.00
IMUX income_statement (quarterly, 2025-09-30) — Basic EPS: -1.30
IMUX cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 55310000.00
IMUX cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -67000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 792000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 9000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 35132000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 35132000.00
IMUX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 0.00
IMUX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -67000.00
IMUX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -20140000.00
IMUX cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -31000.00
IMUX cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 1428000.00
IMUX cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 384000.00
IMUX cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -44000.00
IMUX cash_flow (quarterly, 2025-09-30) — Change In Payable: -31000.00
IMUX cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 1397000.00
IMUX cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 1737000.00
IMUX cash_flow (quarterly, 2025-09-30) — Changes In Cash: -20207000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Common Stock: 9000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 10499000.00
IMUX cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
IMUX balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 17687000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Current Assets: 39273000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 666000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 666000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 30079000.00
IMUX cash_flow (quarterly, 2025-09-30) — Depreciation: 40000.00
IMUX cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 40000.00
IMUX cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 40000.00
IMUX income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 19389776.00
IMUX income_statement (quarterly, 2025-09-30) — Diluted EPS: -1.30
IMUX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -25579000.00
IMUX income_statement (quarterly, 2025-09-30) — EBIT: -25993000.00
IMUX income_statement (quarterly, 2025-09-30) — EBITDA: -25953000.00
IMUX cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 29000.00
IMUX cash_flow (quarterly, 2025-09-30) — End Cash Position: 35132000.00
IMUX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 0.00
IMUX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -20207000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 2582000.00
IMUX income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 5981000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Gross PPE: 1431000.00
IMUX income_statement (quarterly, 2025-09-30) — Interest Income: 419000.00
IMUX income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 419000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Invested Capital: 10499000.00
IMUX cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -67000.00
IMUX cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
IMUX balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 126000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 126000.00
IMUX cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
IMUX cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 0.00
IMUX income_statement (quarterly, 2025-09-30) — Net Income: -25579000.00
IMUX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -25579000.00
IMUX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -25579000.00
IMUX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -25579000.00